AS/Spondyloarthritis

A clinical trial in early axial spondyloarthritis (axSpA) demonstrated sustained inactive disease status in over 60% of patients. In axSpA patients with less than 1 year of disease symptoms, male sex…

Extra-musculoskeletal manifestations (EMMs) occur in patients with spondyloarthritis.The prevalence of EMMs such as uveitis, psoriasis and inflammatory bowel disease are 26%, 9% and 7% respectively…

Dr. Jack Cush reviews FDA approval, news and journal articles -- and it’s the week before EULAR 2024 in Vienna!!FDA has approved upadacitinib (Rinvoq), for use in pediatric patients (age >2 years…